Saltar al contenido
Black Friday — 30% OFFEnvío gratis en pedidos desde 99 €
  1. Inicio
  2. Recuperación y regeneración
  3. Cartalax, 20mg
Recuperación

Cartalax, 20mg

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue.

Presentación: Cartalax, 20mg.

Envase ilustrativo generado con IA.

El precio original era: 70 €.El precio actual es: 49 €.

No disponible actualmente en España

Consulta a un asesor
Un asesor se pone en contacto contigo y la farmacia asociada comprueba si es posible continuar y cómo. Puede ser necesaria una receta válida o una evaluación a través de un servicio de telemedicina autorizado.
  • Farmacia asociada
  • Atención personalizada
  • Entrega discreta
  • Presentación
    Cartalax, 20mg

Envío y entrega

  • Envío habitual en 24 horas tras confirmarse el pago.
  • USPS Regular Shipping · 11,95 € · Aprox. 3–5 días laborables
  • FedEx 2 Days Delivery · 28,99 € · Aprox. 2 días laborables
  • FedEx Overnight Delivery · 40,99 € · Aprox. 1 día laborable

Solo para investigación de laboratorio.

No apto para uso humano o veterinario.

Composición y detalles del producto

Descripción

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation.

Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Propiedades

Chemical Formula C12H19N3O8
Synonyms T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid
Molar Mass 333.29 g/mol
CAS Number 205640-90-0
PubChem CID 87815447
Total Compound Content 20 mg per vial
Shelf Life 36 months

Investigación

Cartalax is a cartilage-derived short peptide bioregulator from the Khavinson series with proposed tissue-specific regulatory activity in cartilaginous tissue. Research from the originating laboratory reports effects on chondrocyte signalling, collagen II synthesis, proteoglycan expression, and extracellular matrix regulation. Research applications include cartilage biology, chondrocyte function, ECM pathway investigation, and short peptide bioregulator mechanism studies. Independently third-party HPLC-tested; COA available per batch.

FAQ

What cartilage extracellular matrix markers have been examined in Cartalax research?

Research from the originating laboratory has focused on key cartilage extracellular matrix markers including collagen type II, aggrecan, and SOX9, which are central regulators of chondrocyte phenotype and cartilage matrix production. These markers are commonly used to evaluate cartilage signalling, extracellular matrix maintenance, and chondrocyte activity in experimental models.

How does Cartalax fit within the Khavinson bioregulator series?

Cartalax is the cartilage-focused member of the Khavinson peptide bioregulator series. Similar to other organ-specific bioregulators, it is proposed to influence tissue-specific regulatory pathways and is primarily investigated in studies involving cartilage biology, chondrocyte function, extracellular matrix regulation, and peptide-mediated gene expression mechanisms.

What experimental models are commonly used to investigate Cartalax?

Common models include primary chondrocyte cultures, cartilage-derived cell lines, three-dimensional cartilage culture systems, and rodent cartilage research models. Frequently measured endpoints include collagen II expression, aggrecan production, SOX9 signalling, extracellular matrix composition, glycosaminoglycan content, and chondrocyte proliferation markers.